002332.SZ
Zhejiang Xianju Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 8.44
+0.00%Year over year
Reported trailing growth
- Revenue
- -7.6%
- EBITDA
- —
- EBIT
- -35.2%
- EPS
- +2.2%
- Free cash flow
- +156.7%
- Operating cash flow
- +18.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -5.0%
- EBITDA
- -13.4%
- EBIT
- -18.7%
- Net income
- -15.7%
- EPS
- -15.9%
- Free cash flow
- -51.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026